Stephen D. Smith

5.0k citations

127 papers · 1.7k · h-index 21

Impact in

Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment
Genetics top 2%
- Chronic Lymphocytic Leukemia Research

Papers in

Pathology and Forensic Medicine 80
- Lymphoma Diagnosis and Treatment 80
Oncology 55
- CAR-T cell therapy research 23
- Viral-associated cancers and disorders 20
- Cancer Immunotherapy and Biomarkers 7

Co-authors: Eric D. Hsi (4 shared papers)Sarah L. Ondrejka (2 shared papers)Raymond Lai (1 shared paper)Ajay K. Gopal (55 shared papers)Ariel L. Rivas (10 shared papers)Mazyar Shadman (39 shared papers)Brian G. Till (40 shared papers)Ryan D. Cassaday (28 shared papers)
Journals: Blood (45 papers)Journal of Clinical Oncology (12 papers)British Journal of Haematology (11 papers)Hematological Oncology (5 papers)Blood Advances (4 papers)
Partner nations: United States South Africa France

In The Last Decade

Stephen D. Smith

115 papers receiving 1.6k citations

Peers

Countries citing papers authored by Stephen D. Smith

Since Specialization

Citations

This map shows the geographic impact of Stephen D. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Smith more than expected).

Fields of papers citing papers by Stephen D. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Smith. The network helps show where Stephen D. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen D. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen D. Smith Line = papers co-authored together Stephen D. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma Blood ·Ariela Noy, Sven de Vos, Catherine Thiéblemont, Peter Martin, Christopher R. Flowers, Franck Morschhauser, Graham P. Collins, Shuo Ma, Morton Coleman, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Alina Smith, Brian Munneke, Isaiah W. Dimery, Darrin M. Beaupre, Robert Chen	2017	203
2	Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis Haematologica ·Sarah L. Ondrejka, Raymond Lai, Stephen D. Smith, Eric D. Hsi	2011	120
3	Treatment of Late Infantile Metachromatic Leukodystrophy by Bone Marrow Transplantation New England Journal of Medicine ·William Krivit, Elsa Shapiro, William R. Kennedy, Meryl Lipton, Lawrence A. Lockman, Stephen D. Smith, C. Gail Summers, David A. Wenger, Michael Y. Tsai, Norma K.C. Ramsay, John H. Kersey, Jeffrey Yao, Edward M. Kaye	1990	106
4	Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy British Journal of Haematology ·Stephen D. Smith, Brian G. Till, Mazyar Shadman, Ryan C. Lynch, Andrew J. Cowan, Qian Wu, Jenna Voutsinas, Heather A. Rasmussen, Katherine Blue, Chaitra S. Ujjani, Andrei R. Shustov, Ryan D. Cassaday, Jonathan R. Fromm, Ajay K. Gopal	2020	72
5	Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis Blood Advances ·Ariela Noy, Sven de Vos, Morton Coleman, Peter Martin, Christopher R. Flowers, Catherine Thiéblemont, Franck Morschhauser, Graham P. Collins, Shuo Ma, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Elizabeth Chong, Shiquan Wu, Leo W.K. Cheung, Kevin Kwei, Bernhard Hauns, Israel Arango‐Hisijara, Robert Chen	2020	69
6	First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL Oncotarget ·John C. Byrd, Stephen D. Smith, Nina D. Wagner‐Johnston, Jeff P. Sharman, Andy I. Chen, Ranjana H. Advani, Bradley Augustson, Paula Marlton, S. Renee Commerford, Kwame Okrah, Lichuan Liu, Elaine Murray, Elicia Penuel, Ashley F. Ward, Ian W. Flinn	2018	68
7	Spatial distribution of acaricide profiles (Boophilus microplus strains susceptible or resistant to acaricides) in southeastern Mexico Veterinary Parasitology ·Roger Iván Rodríguez‐Vivas, Ariel L. Rivas, Gerardo Chowell, S.H. Fragoso, C.R. Rosario, Z. García, Stephen D. Smith, Jason Williams, Steven J. Schwager	2007	65
8	Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. Journal of Clinical Oncology ·Naomi Winick, Stephen D. Smith, J J Shuster, SJ Lauer, Moody D. Wharam, Vita J. Land, G. R. Buchanan, Gaston K. Rivera	1993	47
9	Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen Bone Marrow Transplantation ·Stephen D. Smith, Brian J. Bolwell, Lisa Rybicki, Stacey Brown, Robert M. Dean, M Kalaycio, Ronald Sobecks, S Andresen, Eric D. Hsi, Brad Pohlman, John Sweetenham	2007	41
10	Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study The Lancet Haematology ·Ryan C. Lynch, Ryan D. Cassaday, Stephen D. Smith, Jonathan R. Fromm, Andrew J. Cowan, Edus H. Warren, Mazyar Shadman, Andrei R. Shustov, Brian G. Till, Chaitra S. Ujjani, Edward N. Libby, Mary Philip, Hilary Coye, Christen N. Martino, Sandra L Bhark, Karolyn Morris, Heather Rasmussen, Fatemeh Behnia, Jenna Voutsinas, Ajay K. Gopal	2021	38
11	The non‐relapse mortality rate for patients with diffuse large B‐cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls British Journal of Haematology ·Brian T. Hill, Lisa Rybicki, Brian J. Bolwell, Stephen D. Smith, Robert M. Dean, Matt Kalaycio, Brad Pohlman, Shawnda Tench, Ronald Sobecks, Steven Andrèsen, Edward A. Copelan, John Sweetenham	2011	37
12	Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission Biology of Blood and Marrow Transplantation ·Andrew J. Cowan, Philip A. Stevenson, Ryan D. Cassaday, Solomon A. Graf, Jonathan R. Fromm, David Wu, Leona Holmberg, Brian G. Till, Thomas R. Chauncey, Stephen D. Smith, Mary Philip, Johnnie J. Orozco, Andrei R. Shustov, Damian J. Green, Edward N. Libby, William Bensinger, Mazyar Shadman, David G. Maloney, Oliver W. Press, Ajay K. Gopal	2015	32
13	Prevention of Deterioration in Metachromatic Leukodystrophy by Bone Marrow Transplantation The American Journal of the Medical Sciences ·William Krivit, Meryl Lipton, Lawrence A. Lockman, Michael Y. Tsai, P. James B. Dyck, Stephen D. Smith, Norma K.C. Ramsay, John Kersey	1987	31
14	Twice-Weekly Oral MLN9708 (Ixazomib Citrate), An Investigational Proteasome Inhibitor, In Combination With Lenalidomide (Len) and Dexamethasone (Dex) In Patients (Pts) With Newly Diagnosed Multiple Myeloma (MM): Final Phase 1 Results and Phase 2 Data Blood ·Paul G. Richardson, Craig C. Hofmeister, Cara A. Rosenbaum, Myo Htut, David H. Vesole, Jesús G. Berdeja, Michaela Liedtke, Ajai Chari, Stephen D. Smith, Daniel Lebovic, Deborah Berg, Eileen Liao, Neeraj Gupta, Alessandra Di Bacco, Jose Estevam, Ai‐Min Hui, Rachid Baz	2013	28
15	Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma British Journal of Haematology ·Paul G. Richardson, Craig C. Hofmeister, Cara A. Rosenbaum, Myo Htut, David H. Vesole, Jesús G. Berdeja, Michaela Liedtke, Ajai Chari, Stephen D. Smith, Daniel Lebovic, Noopur Raje, Catriona Byrne, Eileen Liao, Neeraj Gupta, Alessandra Di Bacco, Jose Estevam, Deborah Berg, Rachid Baz	2018	27
16	Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres British Journal of Haematology ·Stephen D. Smith, Craig H. Moskowitz, Robert M. Dean, Brad Pohlman, Ronald Sobecks, Edward A. Copelan, Steven Andrèsen, Brian J. Bolwell, Jocelyn Maragulia, Jill Vanak, John Sweetenham, Alison J. Moskowitz	2011	27
17	A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib Blood ·Allison Winter, Daniel J. Landsburg, Anthony R. Mato, Krista M. Isaac, Francisco J. Hernandez‐Ilizaliturri, Nishitha Reddy, Stephen D. Smith, Mazyar Shadman, Mitchell R. Smith, Paolo Caimi, Deepa Jagadeesh, Brian T. Hill	2017	27
18	Adverse Events in Pediatric Patients Receiving Long-Term Outpatient Antimicrobials Journal of the Pediatric Infectious Diseases Society ·S.C. Olson, Stephen D. Smith, Scott J. Weissman, Matthew P. Kronman	2014	25
19	The Novel SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in a Phase 2a Study in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma Blood ·Sarah McCue Horwitz, Tatyana Feldman, Brian Hess, Michael S. Khodadoust, Youn H. Kim, Javier Muñoz, Manish R. Patel, Tycel Phillips, Stephen D. Smith, Sonali M. Smith, Ryan A. Wilcox, Andrew J. Steele, Anjali Pandey, Matt Birrell, Janet M. Leeds, Pamela B. Conley, Glenn Michelson, Gregory P. Coffey, John T. Curnutte, Paul A. Hamlin	2018	23
20	A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma Blood ·Sarah McCue Horwitz, Tatyana Feldman, Brian Hess, Michael S. Khodadoust, Youn H. Kim, Javier Muñoz, Manish R. Patel, Tycel Phillips, Stephen D. Smith, Sonali M. Smith, Ryan A. Wilcox, Matt Birrell, Janet M. Leeds, Pamela B. Conley, Glenn Michelson, Gregory P. Coffey, John T. Curnutte, Paul A. Hamlin	2019	23

About Stephen D. Smith

Stephen D. Smith is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Dermatology and Hematology, having authored 127 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (80 papers), Chronic Lymphocytic Leukemia Research (42 papers), CAR-T cell therapy research (23 papers), Viral-associated cancers and disorders (20 papers), Cutaneous lymphoproliferative disorders research (14 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (914 citations), Genetics (506 citations), Oncology (653 citations), Hematology (240 citations) and Neurology (180 citations). Stephen D. Smith has collaborated with scholars based in United States, South Africa and France. Frequent co-authors include Eric D. Hsi, Sarah L. Ondrejka, Raymond Lai, Ajay K. Gopal, Ariel L. Rivas, Mazyar Shadman, Brian G. Till, Ryan D. Cassaday, Sven de Vos and Morton Coleman. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Hematological Oncology and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Stephen D. Smith

Impact in

Papers in i

In The Last Decade

Stephen D. Smith

Peers

Countries citing papers authored by Stephen D. Smith

Fields of papers citing papers by Stephen D. Smith

All Works

About Stephen D. Smith

Explore authors with similar magnitude of impact

Papers in